Admetsys
Develops integrated clinical robotics and continuous blood diagnostics for critical care and surgery. The platform combines continuous extracorporeal blood biosensing with real-time computational models of patient metabolism to enable autonomous, closed‑loop regulation of blood glucose and to inform early detection of metabolic deterioration such as sepsis.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Clinical automation controller for metabolic regulation
A clinical robotics controller that captures biosensor data, constructs a real-time metabolic model for each patient, and autonomously administers optimized insulin and dextrose therapy to achieve target glucose ranges.
Cartridge-based continuous blood diagnostic system
An extracorporeal, cartridge-based diagnostic subsystem providing continuous whole-blood measurements for multiple analytes (initially glucose, lactate, temperature, hematocrit) with multi-day operation and no net blood loss.
Intravenous Laboratory™
Real-time continuous blood diagnostics system providing automated extracorporeal whole-blood biosensing with zero blood loss, cartridge-based design with 4 analytes (blood glucose, lactate, temperature, hematocrit) expandable to 20 analytes, enabling up to 7 days of continuous biosensing.
PrecisionOne™
Clinical automation controller that captures data from biosensors, constructs an AI model of patient metabolism in real time, and autonomously regulates patient glucose by infusing optimized insulin and dextrose therapy.
Clinical automation controller for metabolic regulation
A clinical robotics controller that captures biosensor data, constructs a real-time metabolic model for each patient, and autonomously administers optimized insulin and dextrose therapy to achieve target glucose ranges.
Cartridge-based continuous blood diagnostic system
An extracorporeal, cartridge-based diagnostic subsystem providing continuous whole-blood measurements for multiple analytes (initially glucose, lactate, temperature, hematocrit) with multi-day operation and no net blood loss.
Intravenous Laboratory™
Real-time continuous blood diagnostics system providing automated extracorporeal whole-blood biosensing with zero blood loss, cartridge-based design with 4 analytes (blood glucose, lactate, temperature, hematocrit) expandable to 20 analytes, enabling up to 7 days of continuous biosensing.
PrecisionOne™
Clinical automation controller that captures data from biosensors, constructs an AI model of patient metabolism in real time, and autonomously regulates patient glucose by infusing optimized insulin and dextrose therapy.
Expertise Areas
- Closed-loop glycemic control in critical care
- Continuous extracorporeal blood monitoring
- AI-driven physiological and metabolic modeling
- Clinical study execution and device validation
Key Technologies
- Continuous blood biosensing
- Closed-loop drug delivery
- AI-driven real-time metabolic modeling
- Cartridge-based multiplex assays
News & Updates
Press announcement reporting FDA Breakthrough Device designation for the company's autonomous clinical robotics system.
Press announcement reporting CE Mark approval for the automated glycemic control and continuous diagnostics system.
Reported outcomes from three U.S. clinical trials: 97% time-in-range (80–125 mg/dL), 100% prevention of hypoglycemia under 70 mg/dL, and 2.5 hours mean time to normoglycemia.
Reported receipt of FDA Breakthrough designation for the autonomous clinical robotics system.
Reported CE Mark approval for the automated glycemic control and continuous diagnostics system.
Press announcement reporting FDA Breakthrough Device designation for the company's autonomous clinical robotics system.
Press announcement reporting CE Mark approval for the automated glycemic control and continuous diagnostics system.
Reported outcomes from three U.S. clinical trials: 97% time-in-range (80–125 mg/dL), 100% prevention of hypoglycemia under 70 mg/dL, and 2.5 hours mean time to normoglycemia.
Reported receipt of FDA Breakthrough designation for the autonomous clinical robotics system.
Reported CE Mark approval for the automated glycemic control and continuous diagnostics system.